Study uses bioluminescence imaging to detect, monitor eye cancer

10/14/2009 | PhysOrg.com

Chinese researchers performed bioluminescence imaging using the NightOwl LB 981 Molecular Imaging System to monitor the growth and spread of human eye tumors created in mice. "BLI allowed sensitive and quantitative localization and monitoring of intraocular and metastatic tumor growth in vivo and thus might be a useful tool to study cancer biology as well as anti-cancer therapies," the lead researcher said.

View Full Article in:

PhysOrg.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director Quality Improvement
Molina Healthcare of Texas
San Antonio, TX
Senior Medical Director
Network Health
Medford, MA
SVP/Head of Health Plans and Managed Care
Avalere Health
Washington, DC
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR